{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":513,"items":[{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:41:47Z","timestamp":1761054107250,"version":"build-2065373602"},"reference-count":6,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["wchh.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Practical Diabetes"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1002\/pdi.2486","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T07:46:10Z","timestamp":1701848770000},"page":"36-38","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1002","volume":"40","author":[{"given":"Keurene","family":"Kasongo","sequence":"first","affiliation":[{"name":"Medical Student, University of Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"McKay","sequence":"additional","affiliation":[{"name":"Consultant Physician &amp; Clinical Pharmacologist, Glasgow Royal Infirmary, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.254"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.255"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12123"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201710001-00119"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001334"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000967"}],"container-title":["Practical Diabetes"],"language":"en","link":[{"URL":"https:\/\/wchh.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pdi.2486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:17:38Z","timestamp":1761052658000},"score":21.530502,"resource":{"primary":{"URL":"https:\/\/wchh.onlinelibrary.wiley.com\/doi\/10.1002\/pdi.2486"}},"issued":{"date-parts":[[2023,11]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1002\/pdi.2486"],"URL":"https:\/\/doi.org\/10.1002\/pdi.2486","archive":["Portico"],"ISSN":["2047-2897","2047-2900"],"issn-type":[{"type":"print","value":"2047-2897"},{"type":"electronic","value":"2047-2900"}],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"2023-12-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]},{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:04:08Z","timestamp":1715083448889},"publisher-location":"2215 Constitution Avenue, N.W. Washington, DC 20037-2985","reference-count":0,"publisher":"The American Pharmacists Association","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2017,1]]},"DOI":"10.21019\/druginformation.linaclotide","type":"book-chapter","created":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T19:09:36Z","timestamp":1492456176000},"source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.21019","member":"23","published-online":{"date-parts":[[2017,3,24]]},"container-title":["PharmacotherapyFirst Drug Information"],"language":"en","deposited":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T12:58:55Z","timestamp":1528203535000},"score":21.042206,"resource":{"primary":{"URL":"https:\/\/pharmacylibrary.com\/doi\/10.21019\/druginformation.linaclotide"}},"issued":{"date-parts":[[2017,1]]},"references-count":0,"alternative-id":["10.21019\/druginformation.linaclotide","10.21019\/druginformation"],"URL":"https:\/\/doi.org\/10.21019\/druginformation.linaclotide","published":{"date-parts":[[2017,1]]}},{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:29:16Z","timestamp":1726050556959},"reference-count":1,"publisher":"Qeios","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.32388\/e2ric5","type":"reference-entry","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T23:25:21Z","timestamp":1581117921000},"source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.32388","author":[{"name":"National Cancer Institute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17262","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"ref1","unstructured":"National Cancer Institute. Linaclotide. NCI Thesaurus. Code C81001."}],"container-title":["Definitions"],"language":"en","deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T23:25:21Z","timestamp":1581117921000},"score":20.933365,"resource":{"primary":{"URL":"https:\/\/www.qeios.com\/read\/definition\/77086"}},"issued":{"date-parts":[[2020,2,7]]},"references-count":1,"URL":"https:\/\/doi.org\/10.32388\/e2ric5","published":{"date-parts":[[2020,2,7]]}},{"indexed":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T04:04:51Z","timestamp":1729051491297},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"DOI":"10.1007\/s40278-024-68526-z","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:02:44Z","timestamp":1728964964000},"page":"348-348","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"2029","member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"68526_CR1","doi-asserted-by":"crossref","unstructured":"Salvatore S. Linaclotide for paediatric functional constipation. The Lancet Gastroenterology and Hepatology 9: 191-192, No. 3, Jan 2024. Available from: URL: \nhttps:\/\/dx.doi.org\/10.1016\/S2468-1253(23)00440-5","DOI":"10.1016\/S2468-1253(23)00440-5"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-024-68526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40278-024-68526-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-024-68526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:20:22Z","timestamp":1728966022000},"score":20.581966,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40278-024-68526-z"}},"subtitle":["Diarrhoea: case report"],"issued":{"date-parts":[[2024,10,12]]},"references-count":1,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["68526"],"URL":"https:\/\/doi.org\/10.1007\/s40278-024-68526-z","ISSN":["1179-2051"],"issn-type":[{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2024,10,12]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:55:47Z","timestamp":1648968947440},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s40278-019-58610-9","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T02:56:40Z","timestamp":1551409000000},"page":"152-152","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"1742","member":"297","published-online":{"date-parts":[[2019,3,2]]},"reference":[{"key":"58610_CR1","doi-asserted-by":"crossref","unstructured":"Mascarenhas-Saraiva MJ, et al. Effectiveness and tolerability of linaclotide in the treatment of IBS-C in a \"real-life\" setting: Results from a Portuguese single-center study. Neurogastroenterology and Motility 31: e13508, No. 2, Feb 2019. Available from: URL: \n                    http:\/\/doi.org\/10.1111\/nmo.13508\n                    \n                   - Portugal","DOI":"10.1111\/nmo.13508"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-019-58610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-019-58610-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-019-58610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T19:26:19Z","timestamp":1583004379000},"score":20.402683,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-019-58610-9"}},"subtitle":["Diarrhoea: case report"],"issued":{"date-parts":[[2019,3]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["58610"],"URL":"https:\/\/doi.org\/10.1007\/s40278-019-58610-9","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2019,3]]}},{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:43:51Z","timestamp":1778895831984,"version":"3.51.4"},"reference-count":73,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:p>Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy &amp; Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy\/nursing in-services. A comprehensive target drug utilization evaluation\/medication use evaluation (DUE\/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. Subscribers to The Formulary Monograph Service also receive access to a pharmacy bulletin board, The Formulary Information Exchange (The F.I.X.). All topics pertinent to clinical and hospital pharmacy are discussed on The F.I.X. A drug class review is now published monthly with The Formulary Monograph Service.<\/jats:p>\n                  <jats:p>Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service or The F.I.X., call The Formulary at 800-322-4349. The February 2013 monograph topics are tofacitinib, cabozantinib, suvorexant, vortioxetine, and apremilast. The DUE\/MUE is on tofacitinib.<\/jats:p>","DOI":"10.1310\/hpj4802-143","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T21:17:11Z","timestamp":1360099031000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Linaclotide"],"prefix":"10.1177","volume":"48","author":[{"given":"Dennis J.","family":"Cada","sequence":"first","affiliation":[{"name":"Drug Information Center, Washington State University, Spokane, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri L.","family":"Levien","sequence":"additional","affiliation":[{"name":"Drug Information Center, Washington State University, Spokane, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danial E.","family":"Baker","sequence":"additional","affiliation":[{"name":"Drug Information Center, and Professor of Pharmacy Practice, College of Pharmacy, Washington State University Spokane, PO Box 1495, Spokane, Washington 99210-1495."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"bibr1-hpj4802-143","unstructured":"Linzess\n                      [package insert]. St. Louis, MO: Forest Pharmaceuticals; August 2012."},{"key":"bibr2-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.6.770"},{"key":"bibr3-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.1122118"},{"key":"bibr4-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.agast972120"},{"key":"bibr5-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-12-1001"},{"key":"bibr6-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0801447"},{"key":"bibr7-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-009-0027-4"},{"issue":"2","key":"bibr8-hpj4802-143","first-page":"II43","volume":"45","author":"Thompson WG","year":"1999","journal-title":"Gut"},{"key":"bibr9-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04087.x"},{"key":"bibr10-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06120.x"},{"key":"bibr11-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.08.041"},{"issue":"1","key":"bibr12-hpj4802-143","doi-asserted-by":"crossref","first-page":"S-135","DOI":"10.1016\/S0016-5085(11)60550-7","volume":"140","author":"Chey WD","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"bibr13-hpj4802-143","doi-asserted-by":"crossref","first-page":"S-138","DOI":"10.1016\/S0016-5085(11)60561-1","volume":"140","author":"Rao S","year":"2011","journal-title":"Gastroenterology"},{"key":"bibr14-hpj4802-143","first-page":"319","volume":"47","author":"Szkotak J","year":"2012","journal-title":"Formulary"},{"key":"bibr15-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31823d34c3"},{"key":"bibr16-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.0130s2003.x"},{"key":"bibr17-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91055-3"},{"key":"bibr18-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-2-200007180-00013"},{"key":"bibr19-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004409"},{"key":"bibr20-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04153.x"},{"key":"bibr21-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.167270"},{"key":"bibr22-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.12.015"},{"key":"bibr23-hpj4802-143","author":"Ford AC","year":"2008","journal-title":"BMJ"},{"key":"bibr24-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163162"},{"key":"bibr25-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.01.005"},{"key":"bibr26-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-010-0124-1"},{"key":"bibr27-hpj4802-143","volume-title":"Digestive Disease Week","volume":"2012","author":"Shad ED","year":"2012"},{"key":"bibr28-hpj4802-143","unstructured":"Constipation. National Digestive Disease Information Clearinghouse Web site. http:\/\/digestive.niddk.nih.gov\/ddiseases\/pubs\/constipation. Published July 2007. Updated February 21, 2012. Accessed October 10, 2012."},{"key":"bibr29-hpj4802-143","unstructured":"FDA approves\n                      Linzess\n                      to treat certain cases of irritable bowel syndrome and constipation [news release]. Silver Spring, MD: Food and Drug Administration; August 30, 2012. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm317505.htm. Accessed October 10, 2012."},{"key":"bibr30-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318231fc64"},{"key":"bibr31-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.227132"},{"key":"bibr32-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.01.022"},{"key":"bibr33-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01465.x"},{"key":"bibr34-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.09.019"},{"key":"bibr35-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01385.x"},{"key":"bibr36-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.03.015"},{"key":"bibr37-hpj4802-143","unstructured":"CastroJ MartinC HughesPA. A novel role of cyclic GMP in colonic sensory neurotransmission in healthy and TNBS-treated mice [abstract]. Digestive Disease Week 2011; May 7-10, 2011; Chicago, IL. Abstract SU2030."},{"key":"bibr38-hpj4802-143","volume-title":"Digestive Disease Week","volume":"2012","author":"MacDougall JE","year":"2012"},{"key":"bibr39-hpj4802-143","unstructured":"Ironwood and Forest to present linaclotide results from phase 3 trials in patients with irritable bowel syndrome with constipation [news release]. Cambridge, MA: Ironwood Pharmaceuticals; May 4, 2011. http:\/\/www.ironwoodpharma.com\/newsPDF\/DDW.Schedule.IRWD.FRX.05.04.11.pdf. Accessed August 6, 2011."},{"key":"bibr40-hpj4802-143","unstructured":"Ironwood and Forest announce positive linaclotide results from second phase 3 trial in patients with irritable bowel syndrome with constipation [news release]. Cambridge, MA: Ironwood Pharmaceuticals; November 1, 2010. http:\/\/www.ironwoodpharma.com\/newsPDF\/IRWD.FRX.Ph3.MCP-103-302.11.01.10.pdf. Accessed August 6, 2011."},{"key":"bibr41-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.067"},{"issue":"1","key":"bibr42-hpj4802-143","first-page":"1341","volume":"105","author":"Lembo A","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"bibr43-hpj4802-143","volume-title":"Digestive Disease Week","volume":"2012","author":"Castro J","year":"2012"},{"issue":"3","key":"bibr44-hpj4802-143","first-page":"1303","volume":"104","author":"Lavins B","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"bibr45-hpj4802-143","doi-asserted-by":"crossref","first-page":"S-409","DOI":"10.14309\/00000434-200910003-01113","volume":"104","author":"Carson R","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"bibr46-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(09)60140-2"},{"key":"bibr47-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(09)60207-9"},{"issue":"1","key":"bibr48-hpj4802-143","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2982.2010.01587.x","volume":"23","author":"Levine D","year":"2011","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"bibr49-hpj4802-143","first-page":"A35","volume":"61","author":"Lembo AJ","year":"2012","journal-title":"Gut"},{"key":"bibr50-hpj4802-143","doi-asserted-by":"crossref","unstructured":"CheyWD QuigleyEM LavinsBJ. Effects of 26 weeks of linaclotide treatment on adequate relief and IBS severity in patients with irritable bowel syndrome with constipation [abstract]. Digestive Disease Week 2012; May 19-22, 2012; San Diego, CA. Abstract Tu1381.","DOI":"10.1016\/S0016-5085(12)63175-8"},{"issue":"1","key":"bibr51-hpj4802-143","doi-asserted-by":"crossref","first-page":"S-51","DOI":"10.1016\/S0016-5085(11)60207-2","volume":"140","author":"Carson R","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"bibr52-hpj4802-143","first-page":"29","volume":"23","author":"Carson R","year":"2011","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"bibr53-hpj4802-143","first-page":"A348","volume":"61","author":"Carson RT","year":"2012","journal-title":"Gut"},{"key":"bibr54-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(12)62708-5"},{"key":"bibr55-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(12)62859-5"},{"key":"bibr56-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(12)62862-5"},{"key":"bibr57-hpj4802-143","doi-asserted-by":"crossref","unstructured":"SchoenfeldPS ChangL CarsonR. Do baseline factors contribute to treatment satisfaction in patients with chronic constipation treated with linaclotide vs placebo? [abstract] Digestive Disease Week 2012; May 19-22, 2012; San Diego, CA. Abstract Tu1069.","DOI":"10.1016\/S0016-5085(12)62863-7"},{"key":"bibr58-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(12)63174-6"},{"key":"bibr59-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(12)63195-3"},{"key":"bibr60-hpj4802-143","volume-title":"Digestive Disease Week","volume":"2012","author":"Buono JL","year":"2012"},{"key":"bibr61-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(12)63217-X"},{"key":"bibr62-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010863"},{"issue":"1","key":"bibr63-hpj4802-143","first-page":"1303","volume":"105","author":"Lembo A","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"bibr64-hpj4802-143","first-page":"1304","volume":"105","author":"Lembo A","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"bibr65-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(10)60244-2"},{"issue":"1","key":"bibr66-hpj4802-143","doi-asserted-by":"crossref","first-page":"S-202","DOI":"10.1016\/S0016-5085(11)60815-9","volume":"140","author":"Carson R","year":"2011","journal-title":"Gastroenterology"},{"key":"bibr67-hpj4802-143","volume-title":"Digestive Disease Week","volume":"2011","author":"Carson R","year":"2011"},{"issue":"1","key":"bibr68-hpj4802-143","first-page":"29","volume":"23","author":"Carson R","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"bibr69-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.05.070"},{"key":"bibr70-hpj4802-143","volume-title":"Digestive Disease Week","volume":"2011","author":"Johnston JM","year":"2011"},{"key":"bibr71-hpj4802-143","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201110002-01325"},{"issue":"1","key":"bibr72-hpj4802-143","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2982.2010.01587.x","volume":"23","author":"Lembo AJ","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"bibr73-hpj4802-143","unstructured":"KusiakV. NDA approval letter:\n                      Linzess\n                      (linaclotide NDA 202\u2013811). US Food and Drug Administration Web site. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2012\/202811Orig1s000ltr.pdf. Published August 30, 2012. Accessed September 4, 2012."}],"container-title":["Hospital Pharmacy"],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1310\/hpj4802-143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1310\/hpj4802-143","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1310\/hpj4802-143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:32:35Z","timestamp":1777451555000},"score":20.402683,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1310\/hpj4802-143"}},"issued":{"date-parts":[[2013,2]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1310\/hpj4802-143"],"URL":"https:\/\/doi.org\/10.1310\/hpj4802-143","ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"published":{"date-parts":[[2013,2]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T05:10:42Z","timestamp":1648617042373},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s40278-021-88284-6","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T23:05:56Z","timestamp":1609974356000},"page":"465-465","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"1836","member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"88284_CR1","doi-asserted-by":"crossref","unstructured":"Sundararajan T, et al. A rare case of cecal volvulus associated with linaclotide use. American Journal of Gastroenterology 115: S918 abstr. S1777, Oct 2020. Available from: URL: \nhttp:\/\/doi.org\/10.14309\/01.ajg.0000709156.66933.e0 [abstract]","DOI":"10.14309\/01.ajg.0000709156.66933.e0"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-021-88284-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-021-88284-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-021-88284-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T09:08:44Z","timestamp":1610960924000},"score":20.362274,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-021-88284-6"}},"subtitle":["Cecal volvulus: case report"],"issued":{"date-parts":[[2021,1]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["88284"],"URL":"https:\/\/doi.org\/10.1007\/s40278-021-88284-6","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2021,1]]}},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:53:18Z","timestamp":1791881598764,"version":"4.3.4"},"description":"Drug","reference-count":0,"publisher":"Royal Pharmaceutical Society","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.18578\/bnf.818569105","type":"component","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T08:47:16Z","timestamp":1447404436000},"source":"Crossref","is-referenced-by-count":0,"title":["linaclotide"],"prefix":"10.18578","member":"162","deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:28:02Z","timestamp":1791880082000},"score":20.296135,"resource":{"primary":{"URL":"https:\/\/www.medicinescomplete.com\/#\/content\/bnf\/_818569105"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18578\/bnf.818569105","relation":{"is-component-of":[{"id-type":"doi","id":"10.18578\/BNF.147942626","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T04:26:39Z","timestamp":1690604799165},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"DOI":"10.1007\/s40278-023-44022-8","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:02:07Z","timestamp":1690527727000},"page":"215-215","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"1967","member":"297","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"44022_CR1","doi-asserted-by":"crossref","unstructured":"Ali K, et al. LINACLOTIDE INDUCED OXALATE NEPHROPATHY. American Journal of Kidney Diseases 81 (Suppl. 1): S46 abstr. 156, No. 4, Apr 2023. Available from: URL: \nhttp:\/\/doi.org\/10.1053\/j.ajkd.2023.01.158 [abstract]","DOI":"10.1053\/j.ajkd.2023.01.158"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-023-44022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40278-023-44022-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-023-44022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:32:48Z","timestamp":1690529568000},"score":20.16666,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40278-023-44022-8"}},"subtitle":["Oxalate nephropathy: case report"],"issued":{"date-parts":[[2023,7,29]]},"references-count":1,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["44022"],"URL":"https:\/\/doi.org\/10.1007\/s40278-023-44022-8","ISSN":["1179-2051"],"issn-type":[{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2023,7,29]]}},{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T03:02:12Z","timestamp":1726110132621},"edition-number":"0","reference-count":0,"publisher":"CRC Press","isbn-type":[{"type":"electronic","value":"9780429192616"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2015,1,6]]},"DOI":"10.1201\/b17996-77","type":"book-chapter","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T03:27:00Z","timestamp":1607743620000},"page":"210-214","source":"Crossref","is-referenced-by-count":0,"title":["LINACLOTIDE"],"prefix":"10.1201","member":"301","container-title":["Litt's Drug Eruption and Reaction Manual"],"language":"en","deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T10:11:58Z","timestamp":1618049518000},"score":20.162937,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9781498710039\/chapters\/10.1201\/b17996-77"}},"issued":{"date-parts":[[2015,1,6]]},"ISBN":["9780429192616"],"references-count":0,"URL":"https:\/\/doi.org\/10.1201\/b17996-77","published":{"date-parts":[[2015,1,6]]}},{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:45:41Z","timestamp":1755794741712,"version":"3.44.0"},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"DOI":"10.1007\/s40278-025-88405-3","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T05:10:46Z","timestamp":1755321046000},"page":"282-282","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"2072","member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"88405_CR1","doi-asserted-by":"crossref","unstructured":"Xiao Y, et al. Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study. Therapeutic Advances in Gastroenterology 18: 1-13, Jan 2025. Available from: URL: \nhttps:\/\/journals.sagepub.com\/home\/TAG","DOI":"10.1177\/17562848251314819"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-025-88405-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40278-025-88405-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-025-88405-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T05:10:47Z","timestamp":1755321047000},"score":20.093128,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40278-025-88405-3"}},"subtitle":["Haemorrhoid, spontaneous abortion and drug exposure during pregnancy: 2 case reports"],"issued":{"date-parts":[[2025,8,16]]},"references-count":1,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["88405"],"URL":"https:\/\/doi.org\/10.1007\/s40278-025-88405-3","ISSN":["1179-2051"],"issn-type":[{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2025,8,16]]}},{"indexed":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:20:46Z","timestamp":1703290846182},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"DOI":"10.1007\/s40278-023-52082-4","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T06:09:10Z","timestamp":1703225350000},"page":"104-104","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"1988","member":"297","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"key":"52082_CR1","doi-asserted-by":"crossref","unstructured":"Hyams JS, et al. SAFETY OF LINACLOTIDE IN PEDIATRIC PATIENTS WITH FUNCTIONAL CONSTIPATION: A POOLED ANALYSIS OF PLACEBO-CONTROLLED RANDOMIZED-CONTROLLED TRIALS. Gastroenterology 164: S-954, No. 6, May 2023. Available from: URL: \nhttps:\/\/www.gastrojournal.org\/article\/S0016-5085(23)03208-0\/pdf [abstract]","DOI":"10.1016\/S0016-5085(23)03208-0"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-023-52082-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40278-023-52082-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-023-52082-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T06:31:09Z","timestamp":1703226669000},"score":20.047132,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40278-023-52082-4"}},"subtitle":["Severe diarrhoea with dehydration"],"issued":{"date-parts":[[2023,12,23]]},"references-count":1,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["52082"],"URL":"https:\/\/doi.org\/10.1007\/s40278-023-52082-4","ISSN":["1179-2051"],"issn-type":[{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2023,12,23]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:42:17Z","timestamp":1648852937825},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s40278-018-50707-y","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T04:40:51Z","timestamp":1534480851000},"page":"159-159","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"1715","member":"297","published-online":{"date-parts":[[2018,8,18]]},"reference":[{"issue":"7","key":"50707_CR1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1055\/s-0043-124875","volume":"56","author":"V Andresen","year":"2018","unstructured":"Andresen V, et al. Efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in a real-world setting - Results from a German noninterventional study. Zeitschrift fur Gastroenterologie 56: 738-744, No. 7, Jul 2018. Available from: URL: \n                    http:\/\/doi.org\/10.1055\/s-0043-124875\n                    \n                   -Germany","journal-title":"Zeitschrift fur Gastroenterologie"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-018-50707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-018-50707-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-018-50707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T19:21:46Z","timestamp":1566069706000},"score":19.957438,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-018-50707-y"}},"subtitle":["Diarrhoea and abdominal pain: 2 case reports"],"issued":{"date-parts":[[2018,8]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["50707"],"URL":"https:\/\/doi.org\/10.1007\/s40278-018-50707-y","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2018,8]]}},{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T06:08:45Z","timestamp":1715407725788},"publisher-location":"New York, NY","edition-number":"18","reference-count":0,"publisher":"Springer Publishing Company","isbn-type":[{"value":"9780826135582","type":"print"},{"value":"9780826150356","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1891\/9780826150356.0597","type":"book-chapter","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:05:47Z","timestamp":1577142347000},"source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1891","member":"793","container-title":["Hale\u2019s Medications &amp; Mothers\u2019 Milk\u2122 2019"],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/9780826150356.0597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:12:14Z","timestamp":1577142734000},"score":19.913118,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/9780826150356.0597"}},"issued":{"date-parts":[[2018,4]]},"ISBN":["9780826135582","9780826150356"],"references-count":0,"alternative-id":["10.1891\/9780826150356"],"URL":"https:\/\/doi.org\/10.1891\/9780826150356.0597","published":{"date-parts":[[2018,4]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:52:37Z","timestamp":1648680757774},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s40278-018-43193-9","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T17:47:14Z","timestamp":1521222434000},"page":"303-303","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"1693","member":"297","published-online":{"date-parts":[[2018,3,17]]},"reference":[{"key":"43193_CR1","doi-asserted-by":"crossref","unstructured":"Philip NA, et al. When treatment can harm patients: Linaclotide-induced rhabdomyolysis. American Journal of Gastroenterology 112 (Suppl. 1): S1545 abstr. 2887, Oct 2017. Available from: URL: \n                    http:\/\/doi.org\/10.1038\/ajg.2017.346\n                    \n                   [abstract] - USA","DOI":"10.1038\/ajg.2017.346"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-018-43193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-018-43193-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-018-43193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T00:56:16Z","timestamp":1552784176000},"score":19.913118,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-018-43193-9"}},"subtitle":["Various toxicities: case report"],"issued":{"date-parts":[[2018,3]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["43193"],"URL":"https:\/\/doi.org\/10.1007\/s40278-018-43193-9","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2018,3]]}},{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:08:07Z","timestamp":1773173287667,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.2165\/11470590-000000000-00000","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T10:52:34Z","timestamp":1350730354000},"page":"2167-2175","source":"Crossref","is-referenced-by-count":18,"title":["Linaclotide"],"prefix":"10.1007","volume":"72","author":[{"given":"Vanessa","family":"McWilliams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Whiteside","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"McKeage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"R1-9-20121020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/clpt.2011.261","volume":"91","author":"Camilleri","year":"2012 January","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"R2-9-20121020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1756283X10384173","volume":"4","author":"Emmanuel","year":"2011 Jan","journal-title":"Therap Adv Gastroenterol"},{"issue":"12","key":"R3-9-20121020","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1345\/aph.1Q428","volume":"45","author":"Wensel","year":"2011 Dec","journal-title":"Ann Pharmacother"},{"key":"R28-9-20121020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.14309\/00000434-200509001-00894","volume":"100","author":"Currie","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"19-20","key":"R29-9-20121020","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.lfs.2010.03.015","volume":"86","author":"Bryant","year":"2010 May 8","journal-title":"Life Sci"},{"issue":"1-3","key":"R30-9-20121020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejphar.2010.09.019","volume":"649","author":"Busby","year":"2010 Dec 15","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"R31-9-20121020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2982.2009.01385.x","volume":"22","author":"Eutamene","year":"2010 Mar","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"R40-9-20121020","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2010.08.041","volume":"139","author":"Johnston","year":"2010 Dec","journal-title":"Gastroenterology"},{"issue":"3","key":"R42-9-20121020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.gastro.2007.06.067","volume":"133","author":"Andresen","year":"2007 Sep","journal-title":"Gastroenterology"},{"issue":"6","key":"R43-9-20121020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","volume":"365","author":"Lembo","year":"2011 Aug 11","journal-title":"N Engl J Med"},{"issue":"3","key":"R44-9-20121020","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2009.12.050","volume":"138","author":"Lembo","year":"2010 Mar","journal-title":"Gastroenterology"},{"issue":"1","key":"R45-9-20121020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ajg.2008.59","volume":"104","author":"Johnston","year":"2009 Jan","journal-title":"Am J Gastroenterol"}],"container-title":["Drugs"],"language":"en","deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:14:02Z","timestamp":1594772042000},"score":19.902386,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/11470590-000000000-00000"}},"subtitle":["First Global Approval"],"issued":{"date-parts":[[2012,11]]},"references-count":12,"journal-issue":{"issue":"16"},"URL":"https:\/\/doi.org\/10.2165\/11470590-000000000-00000","ISSN":["0012-6667"],"issn-type":[{"value":"0012-6667","type":"print"}],"published":{"date-parts":[[2012,11]]}},{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:00:35Z","timestamp":1768572035764,"version":"3.49.0"},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"DOI":"10.1007\/s40278-026-92225-1","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:27:46Z","timestamp":1768523266000},"page":"64-64","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"2093","member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"92225_CR1","doi-asserted-by":"crossref","unstructured":"Ali O, et al. Oxalate nephropathy precipitated by linaclotide in a high-risk patient. Clinical Nephrology - Case Studies 13: 66-72, Jan 2025. Available from: URL: \nhttps:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC12612843","DOI":"10.5414\/CNCS111722"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-026-92225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40278-026-92225-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-026-92225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:27:50Z","timestamp":1768523270000},"score":19.864937,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40278-026-92225-1"}},"subtitle":["Acute kidney injury and Kidney disorders: case report"],"issued":{"date-parts":[[2026,1,17]]},"references-count":1,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["92225"],"URL":"https:\/\/doi.org\/10.1007\/s40278-026-92225-1","ISSN":["1179-2051"],"issn-type":[{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2026,1,17]]}},{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:08:10Z","timestamp":1697519290184},"reference-count":0,"publisher":"Portico","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1358\/dof.2008.033.07.1214164","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T11:01:47Z","timestamp":1249383707000},"page":"0570","source":"Crossref","is-referenced-by-count":5,"title":["Linaclotide acetate"],"prefix":"10.3730","volume":"33","author":[{"family":"Andresen, V.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Camilleri, M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2008]]},"container-title":["Drugs of the Future"],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T19:52:26Z","timestamp":1685476346000},"score":19.837372,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf78xgw8g"}},"issued":{"date-parts":[[2008]]},"references-count":0,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1358\/dof.2008.033.07.1214164","ISSN":["2013-0368"],"issn-type":[{"value":"2013-0368","type":"print"}],"published":{"date-parts":[[2008]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:40:32Z","timestamp":1648899632961},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40278-020-74767-6","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T05:04:26Z","timestamp":1581138266000},"page":"148-148","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide"],"prefix":"10.1007","volume":"1790","member":"297","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"issue":"12","key":"74767_CR1","doi-asserted-by":"publisher","first-page":"e025627","DOI":"10.1136\/bmjopen-2018-025627","volume":"9","author":"Daniel Pohl","year":"2019","unstructured":"Pohl D, et al. Multicentre, non-interventional study of the efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in primary, secondary and tertiary centres: The Alpine study. BMJ Open 9: No. 12, Dec 2019. Available from: URL:\nhttp:\/\/doi.org\/10.1136\/bmjopen-2018-025627","journal-title":"BMJ Open"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-020-74767-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-020-74767-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-020-74767-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T02:26:37Z","timestamp":1612837597000},"score":19.835583,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-020-74767-6"}},"subtitle":["Abdominal distension: case report"],"issued":{"date-parts":[[2020,2]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["74767"],"URL":"https:\/\/doi.org\/10.1007\/s40278-020-74767-6","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2020,2]]}},{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:35:40Z","timestamp":1726050940074},"reference-count":1,"publisher":"Qeios","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.32388\/0vsjba","type":"reference-entry","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T21:51:44Z","timestamp":1581112304000},"source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide Acetate"],"prefix":"10.32388","author":[{"name":"National Cancer Institute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17262","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"ref1","unstructured":"National Cancer Institute. Linaclotide Acetate. NCI Thesaurus. Code C77223."}],"container-title":["Definitions"],"language":"en","deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T21:51:44Z","timestamp":1581112304000},"score":18.986732,"resource":{"primary":{"URL":"https:\/\/www.qeios.com\/read\/definition\/75069"}},"issued":{"date-parts":[[2020,2,7]]},"references-count":1,"URL":"https:\/\/doi.org\/10.32388\/0vsjba","published":{"date-parts":[[2020,2,7]]}},{"indexed":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:27:25Z","timestamp":1736227645474,"version":"3.32.0"},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"DOI":"10.1007\/s40278-025-73142-y","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:05:36Z","timestamp":1736183136000},"page":"148-148","source":"Crossref","is-referenced-by-count":0,"title":["Azathioprine\/linaclotide\/tamoxifen"],"prefix":"10.1007","volume":"2040","member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"73142_CR1","doi-asserted-by":"crossref","unstructured":"Khandalavala B, et al. A CASE REPORT OF MESENTERIC PANNICULITIS AND FIBROUS DYSPLASIA WITH PRIMARY METABOLIC SYNDROME. European Journal of Case Reports in Internal Medicine 11: No. 12, Jan 2024. Available from: URL: \nhttps:\/\/www.ejcrim.com\/index.php\/EJCRIM\/issue\/view\/120","DOI":"10.12890\/2024_004922"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-025-73142-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40278-025-73142-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-025-73142-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:51:24Z","timestamp":1736185884000},"score":18.129128,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40278-025-73142-y"}},"subtitle":["Venous thromboembolism, drug intolerance and drug ineffective: case report"],"issued":{"date-parts":[[2025,1,4]]},"references-count":1,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["73142"],"URL":"https:\/\/doi.org\/10.1007\/s40278-025-73142-y","ISSN":["1179-2051"],"issn-type":[{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2025,1,4]]}},{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:09:57Z","timestamp":1744430997930,"version":"3.40.4"},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T00:00:00Z","timestamp":1378771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T00:00:00Z","timestamp":1378771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/nrgastro.2013.173","type":"journal-article","created":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T10:40:21Z","timestamp":1378809621000},"page":"567-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide and abdominal pain"],"prefix":"10.1038","volume":"10","author":[{"given":"Isobel","family":"Leake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,10]]},"reference":[{"key":"BFnrgastro2013173_CR1","doi-asserted-by":"crossref","unstructured":"Castro, J.  et al. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic GMP. Gastroenterology doi:10.1053\/j.gastro.2013.08.017","DOI":"10.1053\/j.gastro.2013.08.017"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.173","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:35:39Z","timestamp":1744371339000},"score":17.957048,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.173"}},"issued":{"date-parts":[[2013,9,10]]},"references-count":1,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFnrgastro2013173"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.173","ISSN":["1759-5045","1759-5053"],"issn-type":[{"type":"print","value":"1759-5045"},{"type":"electronic","value":"1759-5053"}],"published":{"date-parts":[[2013,9,10]]},"assertion":[{"value":"10 September 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T03:28:51Z","timestamp":1648697331877},"reference-count":0,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Gastroenterology &amp; Hepatology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1586\/egh.11.90","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T10:11:05Z","timestamp":1323425465000},"page":"15-15","source":"Crossref","is-referenced-by-count":0,"title":["Clarifications about linaclotide"],"prefix":"10.1586","volume":"6","author":[{"given":"Maria","family":"Vazquez-Roque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"container-title":["Expert Review of Gastroenterology &amp; Hepatology"],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/egh.11.90","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T21:11:04Z","timestamp":1481663464000},"score":17.884335,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/egh.11.90"}},"issued":{"date-parts":[[2012,2]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1586\/egh.11.90"],"URL":"https:\/\/doi.org\/10.1586\/egh.11.90","ISSN":["1747-4124","1747-4132"],"issn-type":[{"value":"1747-4124","type":"print"},{"value":"1747-4132","type":"electronic"}],"published":{"date-parts":[[2012,2]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:34:10Z","timestamp":1649183650787},"reference-count":9,"publisher":"MedCrave Group, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OGIJ"],"DOI":"10.15406\/ogij.2015.02.00022","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T10:42:23Z","timestamp":1437475343000},"source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide and Vasomotor Symptoms"],"prefix":"10.15406","volume":"2","author":[{"given":"Keith","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6139","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Freeman EW, Sherif K (2007) Prevalence of hot flushes and night sweats around the world, a systematic review. Climacteric 10(3): 197-214.","DOI":"10.1080\/13697130601181486"},{"key":"ref1","unstructured":"Freedman RR, Norton D, Woodward S, Cornelissen G (1995) Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 80(8): 2354-2358."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3109\/13697137.2011.636847","article-title":"Hot flushes, vascular reactivity and the role of the \u03b1-adrenergic system","author":"Sassarini","year":"2012","unstructured":"Sassarini J, Fox H, Ferrell W, Sattar N, Lumsden M (2012) Hot flushes, vascular reactivity and the role of the \u03b1-adrenergic system. Climacteric 15(4): 332-338.","journal-title":"Climacteric 15(4)"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Deeher DC, Dorries K (2007) Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health 10(6): 247-257.","DOI":"10.1007\/s00737-007-0209-5"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","author":"Drossman","year":"2006","unstructured":"Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130(5): 1377-1390.","journal-title":"Gastroenterology 130(5)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/cgast.s10550","article-title":"Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults","volume":"6","author":"Parker","year":"2013","unstructured":"Parker C, Yuhong Y, Wing Cheong Liu L (2013) Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults. Clinical Medicine Insights: Gastroenterology 6: 21-32.","journal-title":"Clinical Medicine Insights"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.coph.2012.10.005","article-title":"Guanylate cyclase-C receptor activation: unexpected biology","author":"Brierley","year":"2012","unstructured":"Brierley SM (2012) Guanylate cyclase-C receptor activation: unexpected biology. Curr Opin Pharmacol 12(6): 632-640.","journal-title":"Curr Opin Pharmacol 12(6)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00018-011-0815-2","article-title":"Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle","author":"Morgado","year":"2012","unstructured":"Morgado M, Cairrao E, Santos-Silva AJ, Verde I (2012) Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cell Mol Life Sci 69(2): 247-266.","journal-title":"Cell Mol Life Sci 69(2)"},{"key":"ref8","unstructured":"Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhea GJ, et al. (1996) Sildena\ufb01l: an orally active type 5 cyclic GMP-speci\ufb01c phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8(2): 47-52."}],"container-title":["Obstetrics &amp; Gynecology International Journal"],"link":[{"URL":"http:\/\/medcraveonline.com\/OGIJ\/OGIJ-02-00022.php","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T11:02:48Z","timestamp":1574766168000},"score":17.62784,"resource":{"primary":{"URL":"https:\/\/medcraveonline.com\/OGIJ\/linaclotide-and-vasomotor-symptoms.html"}},"issued":{"date-parts":[[2015,1,23]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,23]]}},"URL":"https:\/\/doi.org\/10.15406\/ogij.2015.02.00022","ISSN":["2377-4304"],"issn-type":[{"value":"2377-4304","type":"electronic"}],"published":{"date-parts":[[2015,1,23]]}},{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T05:01:24Z","timestamp":1694062884427},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1683","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>The guanylate cyclase-C receptor agonist linaclotide (Linzess \u2013 Abbvie\/Ironwood) was first approved by the FDA in 2012 for treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.<\/jats:p>","DOI":"10.58347\/tml.2023.1683d","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T15:29:15Z","timestamp":1694014155000},"page":"135-136","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide (Linzess) for Functional Constipation"],"prefix":"10.58347","volume":"65","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2023,8,21]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T15:29:16Z","timestamp":1694014156000},"score":17.194225,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1683d"}},"issued":{"date-parts":[[2023,8,21]]},"references-count":0,"journal-issue":{"issue":"1683","published-online":{"date-parts":[[2023,8,21]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2023.1683d","ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"published":{"date-parts":[[2023,8,21]]}},{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:02:48Z","timestamp":1756425768826,"version":"3.44.0"},"reference-count":20,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:p>Irritable bowel syndrome is a chronic relapsing disorder characterised by abdominal pain or discomfort associated with defaecation, abdominal bloating and a change in bowel habit.1,2 IBS may be classified by the change in bowel function as \u2018diarrhoea predominant\u2019 (IBS-D), \u2018constipation predominant\u2019 (IBS-C) or mixed, or may be unclassified.2 Although it is not thought to be associated with the development of serious disease, IBS is a debilitating condition often resulting in reduced quality of life and significant use of healthcare resources.2,3 Current drug treatment strategies target the patient's predominant symptoms and typically involve the use of an antispasmodic and either a laxative or antidiarrhoeal agent.1 \u25bcLinaclotide (Constella\u2014Almirall) is an oral guanylate cyclase-C receptor agonist licensed for the symptomatic treatment of moderate to severe IBS-C in adults.3, 4 In this article, we consider the evidence for linaclotide and how its use fits with current management strategies for IBS-C.<\/jats:p>","DOI":"10.1136\/dtb.2013.11.0218","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T02:51:33Z","timestamp":1384311093000},"page":"129-132","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["\u25bcLinaclotide for constipation-predominant IBS"],"prefix":"10.1136","volume":"51","member":"239","published-online":{"date-parts":[[2013,11,12]]},"reference":[{"key":"2025082800141416000_51.11.129.1","unstructured":"National Institute for Health and Care Excellence Clinical Knowledge Summaries, 2013. Irritable bowel syndrome [online]. Available: http:\/\/cks.nice.org.uk\/irritable-bowel-syndrome [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.119446"},{"key":"2025082800141416000_51.11.129.3","unstructured":"Committee for Medicinal Products for Human Use (CHMP), 2012. Assessment report. Constella: linaclotide [online]. Available: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002490\/WC500135624.pdf [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.4","unstructured":"Constella 290 micrograms hard capsules. Summary of product characteristics, EU. Almirall Limited, June 2013."},{"key":"2025082800141416000_51.11.129.5","unstructured":"National Institute for Health and Care Excellence, 2008. Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care [online]. Available: http:\/\/www.nice.org.uk\/nicemedia\/live\/11927\/39746\/39746.pdf [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.6","unstructured":"Almirall, 2013. Constella\u00ae (linaclotide), the first approved prescription therapy in a new class of treatments for adults with IBS-C, is now available in Europe [online] . Available: http:\/\/www.almirall.com\/webcorp2\/cda\/comunicacion_detalle_noticia.jsp?id=2518 [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.7","unstructured":"Food and Drug Administration, 2013. FDA approves Linzess to treat certain cases of irritable bowel syndrome and constipation [online]. Available: http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm317505.htm [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4155\/cli.12.95","article-title":"Clinical evidence for the role of linaclotide for the treatment of irritable bowel syndrome","volume":"2","author":"Malagelada","year":"2012","journal-title":"Clin Invest"},{"key":"2025082800141416000_51.11.129.9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.254"},{"key":"2025082800141416000_51.11.129.10","unstructured":"Committee for Proprietary Medicinal Products (CPMP), 2003. Points to consider on the evaluation of medicinal products for the treatment of irritable bowel syndrome [online]. Available: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003187.pdf [Accessed 23\u00a0October 2013]."},{"key":"2025082800141416000_51.11.129.11","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2012. Guidance for industry irritable bowel syndrome\u2014clinical evaluation of drugs for treatment [online]. Available: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM205269.pdf [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.12","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.255"},{"key":"2025082800141416000_51.11.129.13","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12123"},{"key":"2025082800141416000_51.11.129.14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/nmo.12089","article-title":"An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials","volume":"25","author":"Macdougall","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"2025082800141416000_51.11.129.15","doi-asserted-by":"crossref","unstructured":"Sayuk GS . Linaclotide: promising IBS-C efficacy in an era of provisional study endpoints. Am J Gastroenterol 2012; 107: 1726-9.","DOI":"10.1038\/ajg.2012.325"},{"key":"2025082800141416000_51.11.129.16","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q428"},{"key":"2025082800141416000_51.11.129.17","first-page":"15","article-title":"Linaclotide: a guanylate cyclase type-C agonist for the treatment of constipation-predominant irritable bowel syndrome chronic constipation","volume":"47","author":"O'dell","year":"2012","journal-title":"Formulary"},{"key":"2025082800141416000_51.11.129.18","unstructured":"National Institute for Health and Care Excellence, 2013. ESNM16: Irritable bowel syndrome with constipation in adults: linaclotide [online]. Available: http:\/\/www.nice.org.uk\/mpc\/evidencesummariesnewmedicines\/ESNM16.jsp [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.19","unstructured":"Scottish medicines Consortium , 2013. Statement of Advice: linaclotide hard capsules, 290 micrograms (Constella\u00ae). SMC No. (869\/13) [online] Available: http:\/\/www.scottishmedicines.org.uk\/SMC_Advice\/Advice\/869_13_linaclotide_Constella\/linaclotide_Constella [Accessed 23 October 2013]."},{"key":"2025082800141416000_51.11.129.20","unstructured":"All Wales Medicines Strategy Group, 2013. Linaclotide (Constella\u00ae) [online] Available: http:\/\/www.awmsg.org\/awmsgonline\/app\/appraisalinfo\/948 [Accessed 23 October 2013]."}],"container-title":["Drug and Therapeutics Bulletin"],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2013.11.0218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:14:24Z","timestamp":1756365264000},"score":17.124413,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2013.11.0218"}},"issued":{"date-parts":[[2013,11]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,12]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1136\/dtb.2013.11.0218"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2013.11.0218","ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"published":{"date-parts":[[2013,11]]}},{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:09:23Z","timestamp":1762837763063,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Gastroenterology &amp; Hepatology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/s2468-1253(23)00440-5","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T18:30:00Z","timestamp":1704738600000},"page":"191-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide for paediatric functional constipation"],"prefix":"10.1016","volume":"9","author":[{"given":"Silvia","family":"Salvatore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2468-1253(23)00440-5_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(23)00398-9","article-title":"Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","author":"Di Lorenzo","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2468-1253(23)00440-5_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpeds.2016.04.008","article-title":"Prevalence of functional gastrointestinal disorders in children and adolescents","volume":"177","author":"Lewis","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/S2468-1253(23)00440-5_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.nut.2007.04.017","article-title":"Nutritional options for infant constipation","volume":"23","author":"Salvatore","year":"2007","journal-title":"Nutrition"},{"key":"10.1016\/S2468-1253(23)00440-5_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MPG.0000000000000266","article-title":"Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN","volume":"58","author":"Tabbers","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/S2468-1253(23)00440-5_bib6","article-title":"Chronic refractory constipation in children: think beyond stools","volume":"8","author":"Hasosah","year":"2021","journal-title":"Glob Pediatr Health"},{"key":"10.1016\/S2468-1253(23)00440-5_bib7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1053\/j.gastro.2014.09.005","article-title":"Prucalopride is no more effective than placebo for children with functional constipation","volume":"147","author":"Mugie","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/S2468-1253(23)00440-5_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2021.04.005","article-title":"Lubiprostone for pediatric functional constipation: randomized, controlled, double-blind study with long-term extension","volume":"20","author":"Benninga","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2468-1253(23)00440-5_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40272-023-00563-0","article-title":"An update of pharmacological management in children with functional constipation","volume":"25","author":"de Geus","year":"2023","journal-title":"Paediatr Drugs"},{"key":"10.1016\/S2468-1253(23)00440-5_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40272-021-00444-4","article-title":"The use of linaclotide in children with functional constipation or irritable bowel syndrome: a retrospective chart review","volume":"23","author":"Baaleman","year":"2021","journal-title":"Paediatr Drugs"}],"container-title":["The Lancet Gastroenterology &amp; Hepatology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468125323004405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468125323004405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:05:33Z","timestamp":1762837533000},"score":17.086468,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468125323004405"}},"issued":{"date-parts":[[2024,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2468125323004405"],"URL":"https:\/\/doi.org\/10.1016\/s2468-1253(23)00440-5","ISSN":["2468-1253"],"issn-type":[{"type":"print","value":"2468-1253"}],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linaclotide for paediatric functional constipation","name":"articletitle","label":"Article Title"},{"value":"The Lancet Gastroenterology & Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2468-1253(23)00440-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2468-1253(23)00398-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T23:26:02Z","timestamp":1648941962629},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1331\/japha.2012.12544","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T18:44:22Z","timestamp":1355165062000},"page":"860-862","source":"Crossref","is-referenced-by-count":0,"title":["Elvitegravir\/cobicistat, mirabegron, and linaclotide"],"prefix":"10.1016","volume":"52","author":[{"given":"Daniel A.","family":"Hussar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren N.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Journal of the American Pharmacists Association"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115305744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115305744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T04:56:30Z","timestamp":1540011390000},"score":16.808414,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115305744"}},"issued":{"date-parts":[[2012,11]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1544319115305744"],"URL":"https:\/\/doi.org\/10.1331\/japha.2012.12544","ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"published":{"date-parts":[[2012,11]]}},{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:19:58Z","timestamp":1759537198295,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1053\/j.ajkd.2023.01.158","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T04:35:39Z","timestamp":1679373339000},"page":"S46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["156 Linaclotide Induced Oxalate Nephropathy"],"prefix":"10.1053","volume":"81","member":"78","container-title":["American Journal of Kidney Diseases"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862300224X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263862300224X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:49:58Z","timestamp":1759463398000},"score":16.748447,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263862300224X"}},"issued":{"date-parts":[[2023,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S027263862300224X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.01.158","ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"156 Linaclotide Induced Oxalate Nephropathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.01.158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T01:29:36Z","timestamp":1648690176685},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy Today"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/s1042-0991(15)31657-1","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T20:24:15Z","timestamp":1456777455000},"page":"46","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide: Novel treatment for constipation"],"prefix":"10.1016","volume":"18","author":[{"given":"Maria G.","family":"Tanzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Pharmacy Today"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042099115316571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042099115316571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T18:57:54Z","timestamp":1536951474000},"score":16.68145,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042099115316571"}},"issued":{"date-parts":[[2012,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1042099115316571"],"URL":"https:\/\/doi.org\/10.1016\/s1042-0991(15)31657-1","ISSN":["1042-0991"],"issn-type":[{"value":"1042-0991","type":"print"}],"published":{"date-parts":[[2012,10]]}},{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T04:30:43Z","timestamp":1649219443288},"reference-count":0,"publisher":"Royal Pharmaceutical Society","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2015]]},"DOI":"10.1211\/pj.2015.20068161","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T11:57:24Z","timestamp":1443095844000},"source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide, lubiprostone and prucalopride interactions"],"prefix":"10.1211","member":"162","container-title":["The Pharmaceutical Journal"],"deposited":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T11:26:50Z","timestamp":1477049210000},"score":16.324009,"resource":{"primary":{"URL":"http:\/\/www.pharmaceutical-journal.com\/learning\/learning-article\/linaclotide-lubiprostone-and-prucalopride-interactions\/20068161.article"}},"issued":{"date-parts":[[2015]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1211\/pj.2015.20068161","ISSN":["2053-6186"],"issn-type":[{"value":"2053-6186","type":"print"}],"published":{"date-parts":[[2015]]}},{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:40:44Z","timestamp":1715787644957},"publisher-location":"Unitec House, 2 Albert Place, London N3 1QB, UK","reference-count":17,"publisher":"Future Medicine Ltd","isbn-type":[{"value":"9781780842493","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2013,4]]},"DOI":"10.2217\/ebo.13.216","type":"other","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T15:54:41Z","timestamp":1365782081000},"page":"144-152","source":"Crossref","is-referenced-by-count":0,"title":["Newer agents for constipation: linaclotide"],"prefix":"10.2217","author":[{"given":"Danilo","family":"Badiali","sequence":"first","affiliation":[{"name":"Danilo Badiali is a clinical researcher in the Department of Internal Medicine and Medical Specialities of SAPIENZA Rome University and physician in the Gastroentrology Department of the University Hospital Policlinico Umberto I of Rome (Italy). His research interests include the pathophysiology and treatment of functional gastrointestinal disorders and gastrointestinal disorders in patients with neurological diseases."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivano","family":"Biviano","sequence":"additional","affiliation":[{"name":"Ivano Biviano is a trainee in his fourth year of specialization in gastroenterology and digestive endoscopy. His research interests include gastrointestinal motility disorders and functional gastrointestinal disorders."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico Stefano","family":"Corazziari","sequence":"additional","affiliation":[{"name":"Enrico Stefano Corazziari is Professor of Gastroenterology, Head of Gastroenterologia A, University Hospital Policlinico Umberto I, Rome (Italy), and Director of Postgraduate Specialization School of Gastroenterology. His areas of research include chronic gastrointestinal disorders, gastrointestinal motility, functional gastrointestinal disorders, dyspepsia and gastric motor function, biliary dysfunctions and gastrointestinal disorders in neurological patients."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"key":"ch12-bid.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(99)00033-6"},{"key":"ch12-bid.2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014231722696"},{"key":"ch12-bid.3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005080818"},{"key":"ch12-bid.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.03.015"},{"key":"ch12-bid.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.09.019"},{"key":"ch12-bid.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01385.x"},{"key":"ch12-bid.7","first-page":"S-538","volume":"140","author":"Castro J","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"ch12-bid.8","first-page":"S328","volume":"100","author":"Currie MG","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"ch12-bid.9","first-page":"A26","volume":"130","author":"Kurtz CB","year":"2006","journal-title":"Gastroenterology"},{"key":"ch12-bid.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.067"},{"key":"ch12-bid.11","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.59"},{"key":"ch12-bid.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.050"},{"key":"ch12-bid.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010863"},{"key":"ch12-bid.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.08.041"},{"key":"ch12-bid.15","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.255"},{"key":"ch12-bid.16","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.254"},{"key":"ch12-bid.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01465.x"}],"container-title":["Constipation: Current &amp;\u00a0Emerging Treatments"],"language":"en","link":[{"URL":"https:\/\/www.futuremedicine.com\/doi\/pdf\/10.2217\/ebo.13.216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:17:14Z","timestamp":1715786234000},"score":16.263004,"resource":{"primary":{"URL":"https:\/\/librarianresources.taylorandfrancis.com\/future-science-group-platform-migration-library-guide\/ebooks\/"}},"issued":{"date-parts":[[2013,4]]},"ISBN":["9781780842493"],"references-count":17,"alternative-id":["10.2217\/ebo.13.216","10.2217\/9781780842493"],"URL":"https:\/\/doi.org\/10.2217\/ebo.13.216","published":{"date-parts":[[2013,4]]}},{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:39:54Z","timestamp":1772127594163,"version":"3.50.1"},"description":"Supplemental Information for 10.1021\/acs.jmedchem.1c00380","reference-count":0,"publisher":"American Chemical Society (ACS)","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1021\/acs.jmedchem.1c00380.s002","type":"component","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T15:45:31Z","timestamp":1620834331000},"source":"Crossref","is-referenced-by-count":0,"title":["Improving the Gastrointestinal Stability of Linaclotide"],"prefix":"10.1021","member":"316","deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:29:59Z","timestamp":1624505399000},"score":16.014189,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/suppl\/10.1021\/acs.jmedchem.1c00380\/suppl_file\/jm1c00380_si_002.csv"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00380.s002","relation":{"is-component-of":[{"id-type":"doi","id":"10.1021\/acs.jmedchem.1c00380","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:40:40Z","timestamp":1778625640177,"version":"3.51.4"},"reference-count":2,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/nrgastro.2012.194","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T08:28:21Z","timestamp":1349166501000},"page":"616-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Linaclotide approved for constipation-predominant IBS"],"prefix":"10.1038","volume":"9","author":[{"given":"Katrina","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,2]]},"reference":[{"key":"BFnrgastro2012194_CR1","doi-asserted-by":"crossref","unstructured":"Chey, W.  et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am. J. Gastroenterol. doi:10.1038\/ajg.2012.254","DOI":"10.1038\/ajg.2012.254"},{"key":"BFnrgastro2012194_CR2","doi-asserted-by":"crossref","unstructured":"Rao, S.  et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am. J. Gastroenterol. doi:10.1038\/ajg.2012.255","DOI":"10.1038\/ajg.2012.255"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2012.194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2012.194","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2012.194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:23:03Z","timestamp":1744280583000},"score":15.953989,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2012.194"}},"issued":{"date-parts":[[2012,10,2]]},"references-count":2,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFnrgastro2012194"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2012.194","ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"published":{"date-parts":[[2012,10,2]]},"assertion":[{"value":"2 October 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:50:25Z","timestamp":1786999825413,"version":"build-2736575974"},"reference-count":48,"publisher":"American Chemical Society (ACS)","issue":"12","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001821","name":"Vienna Science and Technology Fund","doi-asserted-by":"publisher","award":["LS18-053"],"award-info":[{"award-number":["LS18-053"]}],"id":[{"id":"10.13039\/501100001821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1162503"],"award-info":[{"award-number":["APP1162503"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE150100784"],"award-info":[{"award-number":["DE150100784"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP190101667"],"award-info":[{"award-number":["DP190101667"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["714366"],"award-info":[{"award-number":["714366"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2021,6,24]]},"DOI":"10.1021\/acs.jmedchem.1c00380","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T15:32:56Z","timestamp":1620833576000},"page":"8384-8390","source":"Crossref","is-referenced-by-count":40,"title":["Improving the Gastrointestinal Stability of Linaclotide"],"prefix":"10.1021","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-9636","authenticated-orcid":true,"given":"Nayara","family":"Braga Emidio","sequence":"first","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-1899","authenticated-orcid":true,"given":"Hue N. T.","family":"Tran","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Andersson","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2538-603X","authenticated-orcid":true,"given":"Philip E.","family":"Dawson","sequence":"additional","affiliation":[{"name":"Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8946-0462","authenticated-orcid":true,"given":"Fernando","family":"Albericio","sequence":"additional","affiliation":[{"name":"CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, and Department of Organic Chemistry, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Vetter","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia"},{"name":"School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, QLD 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1996-4646","authenticated-orcid":true,"given":"Markus","family":"Muttenthaler","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia"},{"name":"Institute of Biological Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.08.017"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.08.041"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.09.019"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1586\/egh.11.30"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2010.12.005"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.3390\/toxins2082028"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.3390\/toxins2092213"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.22.10464"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2018.01.005"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.199430"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.06.018"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.07.009"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1007\/BF02931985"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2014.06.012"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)40711-3"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200502300"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1515\/bmc-2015-0035"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201000620"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.201600402"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0504613102"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00957"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201401058"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-018-0039-y"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.9b00207"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1021\/cr400401e"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan3398"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4165"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1021\/ja910602h"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1021\/jm100989w"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1002\/psc.1075"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201104169"},{"key":"ref32\/cit32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1039\/9781847559265-00396","volume-title":"Oxidative folding of peptides and proteins","author":"Muttenthaler M.","year":"2008"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M512419200"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199708831"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1002\/bip.21480"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1021\/mp500809f"},{"key":"ref38\/cit38","first-page":"276","volume":"45","author":"Greenberg R. N.","year":"1997","journal-title":"J. Investig. Med."},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3011.1998.tb01480.x"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)01527-5"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1021\/bi00250a010"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3011.1997.tb01188.x"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.779215"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1177\/2050640612474446"},{"key":"ref45\/cit45","first-page":"154","volume":"38","author":"Thomas R. H.","year":"2013","journal-title":"P T"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.061"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0227-0_4"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.152"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1039\/D0CC02321C"}],"container-title":["Journal of Medicinal Chemistry"],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.1c00380","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.1c00380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T15:44:50Z","timestamp":1682523890000},"score":15.765314,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.1c00380"}},"issued":{"date-parts":[[2021,5,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,6,24]]}},"alternative-id":["10.1021\/acs.jmedchem.1c00380"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00380","ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"published":{"date-parts":[[2021,5,12]]}},{"indexed":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T04:14:31Z","timestamp":1684988071908},"reference-count":0,"publisher":"Portico","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug News Perspect"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1358\/dnp.2010.23.8.1538348","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:10:17Z","timestamp":1549883417000},"page":"515","source":"Crossref","is-referenced-by-count":1,"title":["Molecule of the month. Linaclotide acetate"],"prefix":"10.3730","volume":"23","member":"1320","container-title":["Drug News &amp; Perspectives"],"language":"en","deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T20:48:14Z","timestamp":1684961294000},"score":15.7466135,"resource":{"primary":{"URL":"http:\/\/journals.prous.com\/journals\/servlet\/xmlxsl\/pk_journals.xml_summary_pr?p_JournalId=3&p_RefId=1538348&p_IsPs=N"}},"issued":{"date-parts":[[2010]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1358\/dnp.2010.23.8.1538348","ISSN":["0214-0934"],"issn-type":[{"value":"0214-0934","type":"print"}],"published":{"date-parts":[[2010]]}},{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:13:00Z","timestamp":1759623180923,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Family Practice News"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/s0300-7073(10)71270-6","type":"journal-article","created":{"date-parts":[[2010,12,24]],"date-time":"2010-12-24T04:20:37Z","timestamp":1293164437000},"page":"46-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide Effective for IBS With Constipation"],"prefix":"10.1016","volume":"40","author":[{"given":"DENISE","family":"NAPOLI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Family Practice News"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300707310712706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300707310712706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:54:11Z","timestamp":1759539251000},"score":15.609544,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300707310712706"}},"issued":{"date-parts":[[2010,12]]},"references-count":0,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0300707310712706"],"URL":"https:\/\/doi.org\/10.1016\/s0300-7073(10)71270-6","ISSN":["0300-7073"],"issn-type":[{"type":"print","value":"0300-7073"}],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linaclotide Effective for IBS With Constipation","name":"articletitle","label":"Article Title"},{"value":"Family Practice News","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0300-7073(10)71270-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:39:01Z","timestamp":1772127541023,"version":"3.50.1"},"description":"Supplemental Information for 10.1021\/acs.jmedchem.1c00380","reference-count":0,"publisher":"American Chemical Society (ACS)","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1021\/acs.jmedchem.1c00380.s001","type":"component","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T15:45:31Z","timestamp":1620834331000},"source":"Crossref","is-referenced-by-count":0,"title":["Improving the Gastrointestinal Stability of Linaclotide"],"prefix":"10.1021","member":"316","deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:29:59Z","timestamp":1624505399000},"score":15.609544,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/suppl\/10.1021\/acs.jmedchem.1c00380\/suppl_file\/jm1c00380_si_001.pdf"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00380.s001","relation":{"is-component-of":[{"id-type":"doi","id":"10.1021\/acs.jmedchem.1c00380","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:32:46Z","timestamp":1648873966494},"reference-count":0,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internal Medicine News"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/s1097-8690(11)70785-5","type":"journal-article","created":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T22:33:36Z","timestamp":1317422016000},"page":"30","source":"Crossref","is-referenced-by-count":0,"title":["Investigational Agent Linaclotide Aids Chronic Constipation"],"prefix":"10.1016","volume":"44","author":[{"given":"SHARON","family":"WORCESTER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Internal Medicine News"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097869011707855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097869011707855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:23:11Z","timestamp":1543519391000},"score":15.552034,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097869011707855"}},"issued":{"date-parts":[[2011,9]]},"references-count":0,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1097869011707855"],"URL":"https:\/\/doi.org\/10.1016\/s1097-8690(11)70785-5","ISSN":["1097-8690"],"issn-type":[{"value":"1097-8690","type":"print"}],"published":{"date-parts":[[2011,9]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:23:03Z","timestamp":1649125383900},"reference-count":0,"publisher":"Royal Pharmaceutical Society","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2013]]},"DOI":"10.1211\/pj.2013.11121582","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T11:57:24Z","timestamp":1443095844000},"source":"Crossref","is-referenced-by-count":0,"title":["Linaclotide launched for IBS with constipation"],"prefix":"10.1211","member":"162","container-title":["The Pharmaceutical Journal"],"deposited":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T11:51:48Z","timestamp":1477050708000},"score":15.537667,"resource":{"primary":{"URL":"http:\/\/www.pharmaceutical-journal.com\/news-and-analysis\/linaclotide-launched-for-ibs-with-constipation\/11121582.article"}},"issued":{"date-parts":[[2013]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1211\/pj.2013.11121582","ISSN":["2053-6186"],"issn-type":[{"value":"2053-6186","type":"print"}],"published":{"date-parts":[[2013]]}}],"items-per-page":40,"query":{"start-index":0,"search-terms":null}}}